DIN 02473569 — KISQALI 200 MG
KISQALI is a tablet of Ribociclib marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Ribociclib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02473569
- Brand name
- KISQALI
- Active ingredient
- Ribociclib
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Cyclin-dependent kinase 4/6 (CDK4/6) inhibitor (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.